The Board of Directors oversees the organization and is responsible for ensuring that the activities of CLSI foster and are consistent with the organization’s vision and mission and its status as a tax-exempt organization.
The Chairholders Council has overall responsibility for managing the development of CLSI consensus documents, and continually improving the document development process. The Council oversees the work of nine consensus committees. It is comprised of nine chairholders, each of whom leads a consensus committee in a particular subject area (Automation and Informatics, Clinical Chemistry and Toxicology, Evaluation Protocols, Hematology, Immunology and Ligand Assay, Microbiology, Molecular Methods, Point-of-Care Testing, and Quality Systems and Laboratory Practices).
The nine consensus committees manage the development of documents and related products in their respective subject areas. As the consensus body, they ensure that each document meets CLSI’s requirements for consensus, technical accuracy, relevancy, and excellence (in essence, they are the document development quality control team). The consensus committee is responsible for final review and approval, and deems documents ready for publication as approved standards/guidelines.
The document development committees (DDCs) are charged by the consensus committees with developing new documents and revising existing ones. (Standing) subcommittees reporting to the consensus committees are more focused and are charged with monitoring and revising published CLSI standards and guidelines on subjects that potentially require frequent revision.
Working groups are formed as a subunit of a (standing) subcommittee. They are appointed to complete specific assignments. Currently, (standing) subcommittees are only associated with the Consensus Committee on Microbiology and the Consensus Committee on Quality Systems and Laboratory Practices.